4 ms·
Wargame the scenarios. You wouldn't want to give one dose on purpose, but reserving a whole bunch of doses to prevent some people from getting only 1 in a wors
by mlyle 6y ago
Wargame the scenarios. You wouldn't want to give one dose on purpose, but reserving a whole bunch of doses to prevent some people from getting only 1 in a worst case scenario is silly.
That 20-70% efficacy number includes the entire period between dose 1 and 2. It looks way better 10 days after dose 1, btw-- MLE around 80%.
e.g. single dose -- 50% efficacy (to be pessimistic); double dose -- 95% efficacy. 10M doses "in flight" monthly. 100 deaths/million/month. Ignore all effects on transmission (to be more pessimistic).
Scenario 1 (no logistics disruption, half held back): 5M dosed with 1 dose at day 0, 5M dosed with 2 doses at 1 month and 5M dosed with 1 dose at 1 month. 250 saved in first month, 725 saved in second month.
Scenario 2 (no logistics disruption, 25% held back): 7.5M dosed with 1 dose at day 0, 7.5M dosed with 2 doses at 1 month and 2.5M dosed with 1 dose at 1 month. 375 saved in first month, 837 saved in second month.
Scenario 3: (100% production disruption, half held back): 5M dosed with 1 dose at day 0; 5M dosed with 2 doses at 1 month. 250 saved in first month, 475 saved in second month.
Scenario 4: (100% production disruption, 25% held back): 7.5M dosed with 1 dose at day 0; 2.5M dosed with 2 doses at 1 month; (5M late for dose 2); 375 saved in first month, 612 saved in second month.
With a 25% reserve, you only get into the unexpected-only-1-dose regimen with a supply disruption of more than 50%... and even then it's still probably better than a 50% reserve.
- wwweston 6y agoThis is a productive line of thinking.
- tehjoker 6y agoI wonder if hitting the delivery targets of 20M per month is going to be achieved. That's the first bottleneck before the vaccine supply.
- mlyle 6y agoRight now, many jurisdictions are supply limited, and most look like they're ramping enough to be supply limited, though still a bit more slowly than I'd like. Lowering reserves would still increase administration rate immediately (though not proportionally). Actually, we might even enter phase 1B in some areas and have a mostly parallel administration system start to come up... It's unclear to me how much of the slowness so far in administration (13.5% of doses allotted are reported as administered so far)... is A) (fixed?) delays in reporting, B) (fixed?) delays in logistics getting doses to administration sites, C) limitations on rate of administration, D) holiday-related slowness. Only C really matters in the long term-- if it is ramping poorly compared to production than that's a problem. But I think it's premature to assume C is limiting when A, B, & D are surely large right now.